Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients

NCT05298072 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT05298072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
Lead sponsor
University Hospital, Essen
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2022
Completion date
December 31, 2023
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiotoxicity, heart failure